Suesse, Marie, Gag, Konrad, Hannich, Malte J., Hamann, Laura, Nass, Robert D., Malter, Michael P., Quesada, Carlos M., Remi, Jan, Moeddel, Gabriel, Knake, Susanne, Schmitt, Friedhelm C., Hirsch, Martin, Kunze, Albrecht, Strzelczyk, Adam and von Podewils, Felix (2021). Informed DEcision for cerebrospinal fluid analysis after epiLeptic seizures-the IDEAL-score: A development and validation study. Seizure, 91. S. 228 - 233. LONDON: W B SAUNDERS CO LTD. ISSN 1532-2688

Full text not available from this repository.

Abstract

Background: This observational study was done to develop a score based on clinical predictors that enables a guided decision for the necessity of cerebrospinal fluid (CSF) analysis after first unprovoked epileptic seizures and to validate this score in a retrospective patient cohort. Methods: Clinical predictors were identified by two panels of epilepsy experts and selected according to content validity ratios. Based on these predictors a score was created and applied to a cohort of patients with first epileptic seizures. Results: The IDEAL score consists of 9 items (fever, prolonged disturbance of consciousness, headache, imaging results, cognitive dysfunction, status epilepticus, malignancy, autoimmune encephalitis symptoms) that are collected at two different time points (< 3 h [A-score]; > 3 h [B-score] after hospital admittance). A CSF analysis is recommended, if at least one clinical finding is present, either one of the items evaluated during the acute phase (A-score) or later in the diagnostic process (B-score). In 41 patients (13%) CSF analysis provided essential clues to the cause of the seizure. The combined IDEAL score reached a sensitivity of 98%, a specificity of 53%, a positive predictive value of 24% and a negative predictive value of 99% in this patient cohort. Conclusions: A CSF analysis after first epileptic seizures provided decisive etiological findings in only 13% of all investigated patients. The IDEAL score offers clinicians a simple and easy-to-implement algorithm to assess the necessity of a CSF analysis, and to prevent unnecessary diagnostic procedures.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Suesse, MarieUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gag, KonradUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hannich, Malte J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hamann, LauraUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Nass, Robert D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Malter, Michael P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Quesada, Carlos M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Remi, JanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Moeddel, GabrielUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Knake, SusanneUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schmitt, Friedhelm C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hirsch, MartinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kunze, AlbrechtUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Strzelczyk, AdamUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
von Podewils, FelixUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-600999
DOI: 10.1016/j.seizure.2021.06.019
Journal or Publication Title: Seizure
Volume: 91
Page Range: S. 228 - 233
Date: 2021
Publisher: W B SAUNDERS CO LTD
Place of Publication: LONDON
ISSN: 1532-2688
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
DIAGNOSIS; BLOOD; CSF; AUTOIMMUNEMultiple languages
Clinical Neurology; NeurosciencesMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/60099

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item